chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 7 year old male who was vaccinated with a dose of varicella virus vaccine live. The child was seen on 5/8/04 with definite varicella. Per the mother, the child had all childhood immunizations. It was noted that the child was fine and no therapy was needed. The physician did not want to be contacted for follow up. Unspecified medical attention was sought. There was no product quality complaint involved. No further information has been requested.
Nausea; Diarrhea; All over weakness; I have 100.4°F temp; Vomiting projectile; Body aches and pains; shortness of breath; This is a spontaneous report from a contactable consumer (patient). This patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EL0140), via an unspecified route of administration at single dose on 29Dec2020 06:30 at the hospital for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Dec2020, after receiving vaccine, the patient experienced nausea, diarrhea, all over weakness, I have 100.4°F temp, vomiting projectile, body aches and pains, shortness of breath. The outcome of the events was unknown. The patient stated: "I didn't have any of the symptoms until I got the vaccine, the nausea is a big issue for because I have connected tissue disease and I have to take my medication today. I take Cellcept and Prednisone, every day and I am hoping to get them. I just need to get it in."
Patient had a 30 second tonic clonic seizure 2 days after vaccine. No previous history or seizures.
I have had pain in my lower legs and twitching around my right eye, with some tingling and numbness around the right side of my face.
Racing heart, dizziness, intermediate heart rate. Numbing in left arm, joint aches and tiredness.
This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 26Mar2021 at 15:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, type 2 diabetes mellitus, psoriatic arthritis and possibly sulfonamide allergy. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 27Mar2021 at 08:00, the patient experienced swelling, lump, redness and pain where the vaccine was administered. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, lump, redness and pain were not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
1/14/2021: Dizzy and Chills 1/15/2021: Chills, Headache, Knee/Foot (bottom) pain, bodily itchiness, weakness, flu-like symptoms, sleepy 1/15/2021 @ 1000 hrs: Advil
Dry skin on hands and feet, skin cracking and bleeding, gastrointestinal distress.
He was diagnosed with Guillen Barre syndrome at hospital. Wife reports that his symptoms started on the morning of 12/23/2022 with tingling and no feeling on his right extremities and by the evening spread  to left side. He was taken to hospital and he is still there today.
Mom called office the next day and stated that child wouldn't put any weight on his L leg. She noticed that when he was standing in his crib that morning, his L leg was shaking. Mom noticed some redness and a small bruise. Doctor suggested putting ice packs on the injection spot and incourage him to use leg.
Woke up with a swollen, red, tender left arm 8 days after receiving the first vaccine
Flare up of previously well controlled myasthenia gravis, previously no symptoms of disease s/p thymectomy. Following second booster mRNA Pfizer patient experienced progressive flare of oculobulbar myasthenia symptoms which required hospitalization.
1/7/2021- felt dizzy/nauseas about 30 minutes after injection.  1/8/2021 AM started having soreness in injection site, and some red spots on right hand. PM starting having extreme itching on dorsal sides of hands, used lotion that I normally use (sensitive skin kind) to see if it was just dryness. Red bumps still on just right hand 1/9/2021 woke up in middle of night to extreme itching and spreading red bumps on both hands. Bumps are small and fluid filled. Took Benadryl and went back to bed after washing hands. Early PM continued extreme itching and spreading bumps to wrists becoming more red and some bumps popping. Later in evening I noticed swelling starting in my hands. I have tried Benadryl cream (not difference) washing hands well (no difference) lotion (worse) hydrocortisone 1% cream (itching worse) swelling went from none to a non pitting edema. Hands hurt and swelling increasing over time more bumps showing up on hands (with no other changes to any products I have used)
sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (sore at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (sore at the injection site). At the time of the report, INJECTION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-051690 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051690:Patient's case
Breakthrough case of COVID-19. The first day that I knew that I was sick I had a lot of sinus pain and a headache and fatigue, I had a fever and was shaking really hard, fever was up to 101, I had chills very bad. The next day the chills were gone but I was pretty achy. The symptoms were only for a couple of days. I was so tired that I could not even move, I could not do basic chores, I had a really bad headache. By the third day, it was just hard to get up and I had a very bad chesty cough, and a fever late in the day. The fourth day I was able to get the PAXLOVID. I was still very tired but I was no longer getting a fever or as achy, I was still coughing but not as bad. After taking the PAXLOVID I felt much better. However I still feel crummy and tired and this is still going on now. I feel fine and then try to do some house chores and that would just wipe me out for the day. After about 10 days I went outside for a walk and then the next day I was back to laying down and not being able to do much after that. I have good days and bad days now, I am back to work but I still have days where I cannot function at all.
HIGH DOSE FLUZONE administered by pharmacist on 10-19-15 at 7:00 pm. Developed localized reaction at site within one hour which increased in size and then had some paresthesia in left hand and had malaise when seen on 10-20-15. Had improved by 10-21-15 when phone call to patient.
Starting in 05/2021, I started feeling extremely tired and having lots of headaches. I was getting lack of energy and unable to keep up normal activities. I was always regular with my period until this vaccine. It came 2x in May with heavy bleeding and bad cramps. Then, it would come monthly but heavier and longer than normal. In August, it came 2x and both episodes were so long that it felt like I had my period for the whole month. Cramping in the legs started in November. It continued in December and I developed cramping in the belly with severe body aches. Right before New Years Eve I did an at home test which was negative. Then, I continued to feel worse, so on 12/31/2021 I went to urgent care and got tested for COVID-19 which was positive. I had symptoms like fatigue, chills, night sweating, fever and severe body aches. The worst symptoms were present for about a week, then afterwards I developed an itchy rash on my legs. I put an anti-itch ointment on the rash. The rash is mostly gone (80% gone) but I still experience fatigue all the time and severe cramping with my periods.
sleeping all day; pain at the injection site to left arm; Fever; Headache; legs hurting; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1685), via an unspecified route of administration in the left arm on 07Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on Dec2020 (reported as three weeks ago from 07Jan2021) for COVID-19 immunization and she was fine. The patient got the second COVID vaccine on 07Jan2021 afternoon. The pain at the injection site to left arm started on 07Jan2021 20:00. On 07Jan2021, in the middle of the night, the fever, headache, and legs hurting started. She has been sleeping all day on 08Jan2021 and she does not do this normally. Outcome of the sleeping all day was unknown, of the headache was recovering, of the pain at the injection site to left arm was recovered on 07Jan2021, of the legs hurting and fever was recovered on 08Jan2021.
On 5-4-2021-Patient returned to the pharmacy approximately 5 hours after their vaccination. She was complaining of tightness in her chest and difficulty breathing. She was referred to the local emergency room. On 5-5-2021- I spoke to the patient she said she was just feeling tired today.  The emergency room did an EKG and wanted to observe her for 8 hours. She did not stay for observation. She believes her EKG was ok.
Sore Arm after first vaccine; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received BNT162B2 first dose on 23Mar2021 10:20 Intramuscular on left arm at single dose for COVID-19 immunization. Medical history and Concomitant medications were none. Prior Vaccinations (within 4 weeks) were none. AEs following prior vaccinations were none. Family Medical History Relevant to AEs was None. None Additional Vaccines Administered on Same Date of the Pfizer Suspect. Patient Says with his first dose he had no blood at the injection site he only had a sore arm the next day (24Mar2021) and that was it. Only lasted a couple of hours then it was gone the same day. No AE require a visit to Emergency Room or Physician Office. The outcome of the event was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Baby case: Case number PHHY2015US038994, is an initial literature case report received on 26 Mar 2015. The author in the article discussed about pregnancy and severe influenza infection in the 2013/2014 influenza season. This report refers to a neonate of unknown gender. The neonate's mother current conditions included congenital neutropenia, hypertension and recurrent skin abscesses. The neonate's mother's obstetric history included gravida 2 and para 1. The neonate's mother was on prenatal care. No concomitant medication was reported. The neonate's mother was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. It was reported that the neonate's mother was vaccinated during pregnancy at least two weeks before the onset symptoms. The neonate's mother was evaluated in an outpatient setting for respiratory symptoms and received outpatient care before hospitalization. Four days after the onset of the symptoms the patient received antiviral treatment. On an unknown date after vaccination at 32 weeks of gestation, the neonate's mother experienced neutropenic fever, pneumonia and sepsis (see mother case: PHHY2015US039048). The neonate's mother had an emergent cesarean delivery on admission to alleviate maternal hypoxia and delivered neonate at a gestational age of 32 weeks. The neonate's mother required hemodialysis for acute renal failure, intravenous pressors for low blood pressure and was placed on mechanical ventilation. The outcome of the events neutropenic fever, acute renal failure, pneumonia, low blood pressure, maternal hypoxia and sepsis was not reported. The neonate's mother laboratory results confirmed positive for influenza A infection by polymerase chain reaction (PCR) and subtyped as pH1N1. The neonate's mother had no microbiologic evidence of a bacterial co-infection. The neonate's mother was in the hospital for seven days and the neonate's mother died in the hospital. Seriousness of the event "delivered neonate at a gestational age of 32 weeks" was upgraded based on information available in the source document. The author stated that influenza remains a significant cause of morbidity and mortality in pregnant and postpartum women. Although vaccination was not 100 percent effective given the higher risk of influenza complications among pregnant and postpartum women, it was incumbent that health care providers and obstetricians provide education and counseling to every pregnant woman about its benefits for both mother and neonate. The author concluded that most of the pregnant women in the current literature case series had previously given birth, suggesting the possibility that other small children in the household could also be a source of transmission. Because influenza vaccination was universally recommended, strategies for reducing transmission in pregnant and postpartum women should include vaccination of the entire household unit; likewise, early initiation of antiviral treatment in infected household members who may have close contact with pregnant and postpartum women should be considered.
admitted to the ICU with acute respiratory failure.  h/o DM and HL, prior h/o smoking and EtOH and opium abuse (none x 28 yrs, per family). Received second dose of the Pfizer COVID vaccine in AM of 3/16, having had severe adverse reactions (fever up to 104, n/v) to the first dose three weeks earlier. Experienced recurrent fevers (up to 103) beginning by the evening of 3/16, for which he took acetaminophen.   Awoke at 3 AM w/ recurrent fevers, for which he took ibuprofen. Felt better in AM, had breakfast, and retired back to bed. Awoke shortly after noon w/ severe n/v and AMS. Was brought to the ED by the EMS. Febrile (T 39.6) w/ rigors, tachycardic, tachypneic, and poorly responsive on arrival. Continued to experience episodes of emesis, and was felt to have possibly had a seizure episode ("looked to the side and was shaking"; no clear tonic-clonic movements noted). Was thus intubated for airway protection. Initial laboratory w/u revealed presence of mild leukocytosis (WBC 12.6, 47p49L0Eo), lactic acidosis (LA 5.2), hyperglycemia (glu 297), elevated lipase level (161) renal insufficiency (Cr 1.23). extubated on 3/19.  received antibiotics for positive blood culture (streptococcus parasanguinis).   diagnosis: ADVERSE EFFECT OF CORONAVIRUS COVID-19 VACCINE
Pt arrived for first dose of Pfizer vaccine, no history of reactions to vaccines and no known allergies. Patient did fine initially after her shot, dad denies patient feeling anxious and nurses noted patient seemed calm before and after her vaccine. Pt was sitting/leaning on dad towards the end of her 15 mins, he then felt her become heavy on his arm and noticed she had passed out. Observation nurse and another nurse working the clinic got the patient on her side (she was on a bench seat) and took vitals, put a cold water bottle behind her neck. Initially her bp was low (88/62) and progressively became higher, getting up to 146/98 at one point. Pulse/Respirations were WNL. Patient was in and out of consciousness so EMS was called and transported to Hospital emergency department.  Patient evaluated with EKG, labs, and neurology consult.  Urinalysis consistent with urinary tract infection.  Patient discharged from emergency department with antibiotics and follow-up with primary care provider.
pain; Head ache; Tired; Ball; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head ache), LYMPHADENOPATHY (Ball), PAIN (pain) and FATIGUE (Tired) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 24-Mar-2021, the patient experienced LYMPHADENOPATHY (Ball). On an unknown date, the patient experienced HEADACHE (Head ache), PAIN (pain) and FATIGUE (Tired). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Information has been received from a registered pharmacist referring to a 68 year old male patient. The patient's pertinent medical history and drug reactions/allergies were reported as none. On 30-SEP-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # L035687, expiration date 16-FEB-2017, 0.5 ml, once, intramuscular). Concomitant therapies included a dose of FLUZONE HIGH DOSE which administered in separate injection sites on the same day. On 01-OCT-2016, the patient developed pain at the PNEUMOVAX 23 injection site area that also looked infected. The patient went to an unspecified Emergency Room on the same day due to the reactions and was prescribed unspecified antibiotics as treatment. The patient was not admitted to the unspecified hospital that day. The patient went back to the unspecified Emergency Room on 03-OCT-2016 because it was spreading and getting worse. The patient was admitted to the unspecified hospital on 03-OCT-2016 and was diagnosed with cellulitis (on an unspecified date). The patient was currently still in the hospital. The outcome of cellulitis was reported as not recovered. The causality was not provided. Additional information has been requested.
From initial information received on 08/30/2004 from a physician regarding an adverse event occurring in the USA, it was reported that a 13 year old male patient received a TD ADS Adult vaccination, lot number U0844AA, administered intra-muscularly in the left arm on 08/27/2004.  Within 24 hours the patient developed a fever of 102 degrees and pain in all his extremities.  The events were reported to the physician by the patient's mother on 08/28/2004, and he was seen in the office on 08/30/2004.  The recovery status of the patient was not reported.  From additional information received on 10/04/2004 from the reporting physician, it was noted that the patient's muscle pain resolved after 5 days with no permanent sequelae.  The adverse event coding has been updated to change the event term of pain to muscle pain.  The reporter also provided additional information on 10/18/2004 regarding the event of fever.  It was reported that the patient recovered seven days later and became afebrile.  He was recovered from both of the reported adverse events.  No further information is anticipated, this case is considered closed.
VERY extreme chills that woke me up from my sleep.  My body ached to a point that I could not get up till 2:30 AM where I took my temperature which was 102.6F.  I am pretty sure that my temperature was higher than that as my chills had subsided enough to find my thomometer.  Slowly my temperature went down till it was normal by 2:00 PM on the same date.  I did not call medical help as I was able to breathe clearly and I monitored my body temperature and felt that it was improving over time.
may be because he has come in contact with COVID-19 since his first dose; may be because he has come in contact with COVID-19 since his first dose; symptoms of a cold including "cough, chills, body aches, etc." that continued for 3 days; symptoms of a cold including "cough, chills, body aches, etc." that continued for 3 days; symptoms of a cold including "cough, chills, body aches, etc." that continued for 3 days; symptoms of a cold including "cough, chills, body aches, etc." that continued for 3 days; oxygen levels are going down; This is a spontaneous report from a contactable consumer. A 37-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The reporter stated that his brother (patient) has started having symptoms of a cold including cough, chills, body aches (on unspecified date) that continued for 3 days. His brother reached out to his doctor who told him it may not be related to the shot but may be because he has come in contact with COVID-19 since his first dose. The patient is waiting on a COVID-19 test (unknown (pending) result) but caller is concerned because he state that his oxygen levels were going down. The caller would like to know if the patient can take vitamin supplements after or in between doses of the Pfizer BioNTech COVID-19 vaccine. The reporter specifically asked about vitamins E, C, B, and echinacea. They responded that there is no information regarding a potential interaction between the vaccine and vitamin supplements such as E, C, B, and echinacea. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Pt recvd vax & devel pains in chest, back & arms; placed on Naprosyn, Pred w/o relief; MRI & x-ray showed; no bone changes or arthritis;
More coughing; Trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (More coughing) and DYSPNOEA (Trouble breathing) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (More coughing) and DYSPNOEA (Trouble breathing). At the time of the report, COUGH (More coughing) and DYSPNOEA (Trouble breathing) outcome was unknown.            The concomitant medications were not reported.  Treatment medications include some unknown medication for allergy.   This case was linked to MOD-2021-073201 (Patient Link).
3 hours after receiving pneumonia vaccine her left arm was in pain. 3 days later she could not move the left arm. She called RPH and was advised to call MD and try ibuprofen. She saw MD Monday who determined the injection was given in her joint, not in her muscle. He recommended an MRI.